Van Eck Associates Corp Horizon Therapeutics Public LTD CO Transaction History

Van Eck Associates Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$96.34 - $112.38 $78,709 - $91,814	-817 Reduced 9.4%	7,878 $810,000
Q1 2023 May 03, 2023	SELL	$107.32 - $113.5 $726,234 - $768,054	-6,767 Reduced 43.77%	8,695 $949,000
Q4 2022 Feb 08, 2023	SELL	$62.39 - $113.8 $27,576 - $50,299	-442 Reduced 2.78%	15,462 $1.76 Million
Q3 2022 Oct 27, 2022	BUY	$58.92 - $84.67 $273,153 - $392,530	4,636 Added 41.14%	15,904 $984,000
Q2 2022 Aug 03, 2022	SELL	$79.4 - $116.36 $99,408 - $145,682	-1,252 Reduced 10.0%	11,268 $899,000
Q1 2022 May 10, 2022	BUY	$86.42 - $109.81 $113,037 - $143,631	1,308 Added 11.67%	12,520 $1.32 Million
Q4 2021 Jan 26, 2022	BUY	$98.56 - $119.91 $172,381 - $209,722	1,749 Added 18.48%	11,212 $1.21 Million
Q3 2021 Nov 03, 2021	BUY	$91.91 - $110.37 $186,485 - $223,940	2,029 Added 27.29%	9,463 $1.04 Million
Q2 2021 Aug 10, 2021	BUY	$86.24 - $95.92 $25,440 - $28,296	295 Added 4.13%	7,434 $696,000
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $512,794 - $681,631	7,139 New	7,139 $657,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.